Lie YS - Search Results

1

Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy.

Parkin NT, Lie YS, Hellmann N, Markowitz M, Bonhoeffer S, Ho DD, Petropoulos CJ. Parkin NT, et al. Among authors: lie ys. J Infect Dis. 1999 Sep;180(3):865-70. doi: 10.1086/314928. J Infect Dis. 1999. PMID: 10438382

2

Chinese hamster ovary cells contain transcriptionally active full-length type C proviruses.

Lie YS, Penuel EM, Low MA, Nguyen TP, Mangahas JO, Anderson KP, Petropoulos CJ. Lie YS, et al. J Virol. 1994 Dec;68(12):7840-9. doi: 10.1128/JVI.68.12.7840-7849.1994. J Virol. 1994. PMID: 7966574 Free PMC article.

3

Gene transfer and amplification in CHO cells. Efficient methods for maximizing specific productivity and assessment of genetic consequences.

Wurm FM, Johnson A, Ryll T, Köhne C, Scherthan H, Glaab F, Lie YS, Petropoulos CJ, Arathoon WR. Wurm FM, et al. Among authors: lie ys. Ann N Y Acad Sci. 1996 May 15;782:70-8. doi: 10.1111/j.1749-6632.1996.tb40548.x. Ann N Y Acad Sci. 1996. PMID: 8659926 Review. No abstract available.

4

Advances in quantitative PCR technology: 5' nuclease assays.

Lie YS, Petropoulos CJ. Lie YS, et al. Curr Opin Biotechnol. 1998 Feb;9(1):43-8. doi: 10.1016/s0958-1669(98)80082-7. Curr Opin Biotechnol. 1998. PMID: 9503586 Review.

5

Quantitative competitive reverse transcription-PCR as a method to evaluate retrovirus removal during chromatography procedures.

Lau AS, Lie YS, Norling LA, Sernatinger J, Dinowitz M, Petropoulos CJ, Xu Y. Lau AS, et al. Among authors: lie ys. J Biotechnol. 1999 Oct 8;75(2-3):105-15. doi: 10.1016/s0168-1656(99)00152-2. J Biotechnol. 1999. PMID: 10553652

6

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1.

Petropoulos CJ, Parkin NT, Limoli KL, Lie YS, Wrin T, Huang W, Tian H, Smith D, Winslow GA, Capon DJ, Whitcomb JM. Petropoulos CJ, et al. Among authors: lie ys. Antimicrob Agents Chemother. 2000 Apr;44(4):920-8. doi: 10.1128/AAC.44.4.920-928.2000. Antimicrob Agents Chemother. 2000. PMID: 10722492 Free PMC article.

7

Reply.

Parkin N, Lie Y, Hellmann N, Petropoulos C, Markowitz M, Ho D. Parkin N, et al. J Infect Dis. 2000 May;181(5):1863-4. doi: 10.1086/315416. J Infect Dis. 2000. PMID: 10823805 No abstract available.

8

Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors.

Kemper CA, Witt MD, Keiser PH, Dubé MP, Forthal DN, Leibowitz M, Smith DS, Rigby A, Hellmann NS, Lie YS, Leedom J, Richman D, McCutchan JA, Haubrich R; California Collaborative Treatment Group #575 Team. Kemper CA, et al. Among authors: lie ys. AIDS. 2001 Mar 30;15(5):609-15. doi: 10.1097/00002030-200103300-00010. AIDS. 2001. PMID: 11316998

9

Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations.

Taylor S, Cane P, Hué S, Xu L, Wrin T, Lie Y, Hellmann N, Petropoulos C, Workman J, Ratcliffe D, Choudhury B, Pillay D. Taylor S, et al. AIDS Res Hum Retroviruses. 2003 May;19(5):353-61. doi: 10.1089/088922203765551700. AIDS Res Hum Retroviruses. 2003. PMID: 12803994

10

Effects of the G190A substitution of HIV reverse transcriptase on phenotypic susceptibility of patient isolates to delavirdine.

Uhlmann EJ, Tebas P, Storch GA, Powderly WG, Lie YS, Whitcomb JM, Hellmann NS, Arens MQ. Uhlmann EJ, et al. Among authors: lie ys. J Clin Virol. 2004 Nov;31(3):198-203. doi: 10.1016/j.jcv.2004.03.012. J Clin Virol. 2004. PMID: 15465412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters